Polynucleotide immunization has been employed as a expression for this application. Here we further modify the means of inducing immune responses through the introvector for optimal use in gene therapy through the incorporduction of antigen-encoding DNA. While immunization ation of untranslated regions flanking the encoded transagainst specific tumor antigens may be achieved through gene. The ␤-globin 5′ and 3′ untranslated regions (UTRs) this strategy, various candidate tumor antigens may not be were inserted directly flanking the luciferase gene in both approached via DNA-based vaccines as they represent nonreplicative and replicative RNA constructs. In both transforming oncogenes. As an alternative approach, we cases, elevated and prolonged levels of luciferase have explored the utility of mRNA vectors for polynucleoexpression were detected from the ␤-globin UTR-flanked tide immunization. The transient expression achieved by luciferase as compared to luciferase without these mRNA may provide an efficient and safe system for stimulsequences. These modifications improve the ability of repating immune responses to tumor-specific antigens. Our licative RNA vectors to produce high, yet transient transprevious work demonstrated that a self-replicating RNA gene expression for cancer immunotherapy strategies. enhances the magnitude and duration of transgene
The finding that direct intramuscular injection of plasmid heterologous promoter, insertional mutagenesis, and the possibility of cellular transformation as a result of persist-DNA can lead to long-term expression of encoded genes has resulted in the development of novel vaccination ent expression. To circumvent these potential hazards, the use of RNA offers an attractive alternative. Among strategies utilizing DNA-based vaccines. 1 'Polynucleotide immunization' (PNI), the delivery of DNA or RNA into the advantages of RNA as a form of reversible gene therapy are its transient expression and nontransforming cells with resultant transgene expression, has proven an effective means of eliciting a specific humoral and syscharacteristics. In addition, unlike DNA, RNA does not require targeting to the nucleus to achieve transgene temic immune response. Initially developed for vaccination against infectious agents, 2-5 PNI has also been expression. Whereas nucleic acid is efficiently taken up into the cytoplasm, transfer of plasmid DNA to the applied to tumor-specific antigens as a strategy for inducing active specific antitumor immunity for cancer nucleus is a comparatively inefficient process which may represent the primary limitation for successful expression gene therapy. [6] [7] [8] [9] This immunity relies upon the endogenous expression of the antigen for recruitment of cytotoxic from transferred DNA. 12,13 These properties suggest that RNA may be well suited for clinical applications such as T lymphocytes.
Although this mode of immunization is of proven utilinduction of reversible expression of potentially oncogenic tumor-specific antigens. ity in the aforementioned antitumor contexts, several tumor-associated antigens that otherwise represent To date, however, the utility of RNA-based gene therapy approaches has been hampered by the inherent instarational targets for PNI are limited by potential safety concerns. For example, erbB-2 10 and mutant p53 11 repbility of RNA and subsequent low levels of protein expression. Although nonreplicative RNA encoding a resent important tumor-associated antigens that may also contribute to the oncogenic state. Potential risks associatumor-associated antigen has been shown to induce a specific immune response, 14 enhanced expression from ted with DNA-based PNI of such genes include integration of oncogenic sequences under the control of a transferred RNA would likely prove more effective. One method of achieving high levels of protein expression from RNA is based on a self-replicating RNA molecule derived from the Sindbis virus. 15, 16 In this system, the RNA is of positive polarity and encodes the viral nonstructural proteins, which are necessary for RNA self-replication and transcription, in addition to the inserted transgene. When the RNA is transfected into the cytoplasm of cells, the nonstructural proteins are translated by the cellular ribosomes; these viral protein products are then capable of copying the positive RNA genome into negative strands and vice versa. Additionally, these proteins direct high-level, cytoplasmic transcription of the foreign gene sequences from an internal subgenomic promoter. 17 Using this expression system, we have previously demonstrated that the vector TLXN-Luc, in which the viral structural genes have been replaced with the firefly luciferase gene, can effectively increase the magnitude and duration of luciferase expression both in vitro and in vivo when compared to nonreplicative mRNA. 18 In order to achieve greater levels of expression in the replicative RNA system, we examined the use of untranslated regions (UTRs) derived from the Xenopus ␤-globin gene, which have been reported to increase expression from mRNA transcripts. [19] [20] [21] [22] We first studied the speci- As shown in Figure 1 , the addition of ␤-globin UTRs flanking the luciferase gene augmented luciferase expression. In marked contrast, there was no significant augmentation with the addition of nonspecific sequences. We next analyzed the capacity of the ␤-globin UTRs to augment expression of a reporter gene in the context of In four separate experiments, the level of expression from pGT28 was more than 150-fold (range of 86-to 198-fold) a replicative RNA system. For these studies, two Sindbis virus-based vectors were used: TLXN-Luc and ␤-TLXNgreater than that of unflanked pGemLuc at 17 h after transfection, and was more than 40-fold greater at 70 h Luc. The TLXN-Luc vector encodes an approximately 8000 nucleotide RNA transcript consisting of the viral after transfection. The increase in expression of pGemLuc-NS over pGemLuc averaged only 3.3-fold (range of nonstructural genes followed by the luciferase gene, which had been inserted in place of the viral structural 2.8-to 4.1-fold) at 15 h after transfection, and only 2.8-fold after 70 h. Thus, elevated translation of heterologous genes. 18 ␤-TLXN-Luc was derived from TLXN-Luc with the addition of ␤-globin 5′ and 3′ untranslated regions RNA transcripts was achieved through the specific incorporation of flanking ␤-globin UTRs.
flanking the luciferase gene. As a result, the luciferase transcripts produced from the subgenomic promoter subtranscribed from TLXN-Luc or ␤-TLXN-Luc was injected intramuscularly into mice and luciferase activity was sequent to transfection will include the ␤-globin untranslated regions (Figure 2a) . In vitro transcription reactions measured at intervals from 1-5 days. As shown in Figure  3 , in vivo expression from the transcript incorporating the were performed on linearized DNA vectors to produce translation-competent mRNA transcripts which were ␤-globin UTRs was enhanced at all time-points compared to expression from the transcript lacking these sequences. transfected into BHK-21 cells as above. Incorporation of ␤-globin sequences flanking the luciferase gene resulted Thus, the ␤-globin UTRs confer increased expression from a heterologous gene in muscle cells in vivo. in levels of expression that were consistently higher than those achieved without such sequences. Four experi-
The findings presented here demonstrate that additional maneuvers can be undertaken further to ments were performed, with a representative experiment shown in Figure 2b . Augmentation of luciferase enhance expression from transferred RNAs. The incorporation of the ␤-globin sequences flanking the 5′ and 3′ expression with the ␤-globin UTR construct averaged 250-fold (range of 18-to 562-fold) at 15 h after transfecends of the luciferase gene significantly increased both the magnitude and the duration of luciferase expression tion, and was more than 20-fold at 72 h after transfection. Therefore, as with the nonreplicative transcripts, the repwhen compared with RNA without these sequences. When used in a replicative RNA system, the ␤-globin licative RNA exhibited enhanced expression as a result of incorporation of ␤-globin UTRs.
sequences further enhanced protein expression of the reporter gene. These results were consistent both in vitro To determine if the augmentation of expression achieved in vitro was also apparent in vivo, 50 g of RNA in transfected BHK-21 cells, as well as in vivo in murine Figure 1 .
